Reinduction results comparing weekly and every other week PEG-Asp in patients with bone marrow and isolated extramedullary involvement
Patient groups . | Complete remission . | Resistant disease4-150 . | Early death . | |||
---|---|---|---|---|---|---|
qw . | qow . | qw . | qow . | qw . | qow . | |
All patients (n = 144)4-151 | 69 | 60 | 2 | 9 | 0 | 4 |
Bone marrow involvement (n = 126)‡ | 61 | 50 | 2 | 9 | 0 | 4 |
Isolated EM (n = 18) | 8 | 10 | 0 | 0 | 0 | 0 |
Patient groups . | Complete remission . | Resistant disease4-150 . | Early death . | |||
---|---|---|---|---|---|---|
qw . | qow . | qw . | qow . | qw . | qow . | |
All patients (n = 144)4-151 | 69 | 60 | 2 | 9 | 0 | 4 |
Bone marrow involvement (n = 126)‡ | 61 | 50 | 2 | 9 | 0 | 4 |
Isolated EM (n = 18) | 8 | 10 | 0 | 0 | 0 | 0 |